Gastric cancer remains a significant cause of morbidity and mortality worldwide. Surgical resection has been the mainstay of curative therapy for localized and locoregional disease, but high local and distant recurrence rates have led to evaluation of additional therapies. A number of trials have evaluated chemotherapy and/or radiation both in the neoadjuvant and adjuvant settings as additional modalities to improve outcome after surgical resection. Though there is consensus that additional modalities play a role in improving overall survival after curative intent surgery, preference for certain regimens and modalities varies markedly across different regions of the world.
|Original language||English (US)|
|Title of host publication||Minimally Invasive Foregut Surgery for Malignancy|
|Subtitle of host publication||Principles and Practice|
|Publisher||Springer International Publishing|
|Number of pages||13|
|State||Published - Jan 1 2015|
All Science Journal Classification (ASJC) codes